glp-1 alcohol medications get at the heart of addiction: study – WashU Medicine GLP-1 Anti-Obesity Rx and Alcohol

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach

Tirzepatide starts at 2.5 mg weekly

Conceio-Furber and colleagues, in Frontiers in Endocrinology, lay out how turning on the glucagon receptor lifts energy use enough to open a calorie deficit even without any extra appetite suppression

Foley is here to help you address the short- and long-term impacts in the wake of regulatory changes

The cardiorenal effects of both GLP-1RA and SGLT-2 inhibitors can be summarized as follows: GLP-1RA have moderate benefits on MACE (major cardiovascular events), may reduce all-cause mortality and hospitalization for HF (HHF), and have a robust effect in reducing the incidence of macroalbuminuria [12]

Obesity can raise the risk of many other health conditions, including cardiovascular disease